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OBJECTIVE— The purpose of this study was to evaluate the relationship of severe hypogly-
cemia and smoking in a population-based cohort of individuals with long-term type 1 diabetes.
RESEARCH DESIGN AND METHODS— This was a cross-sectional analysis of the
population-based cohort of the Wisconsin Epidemiologic Study of Diabetic Retinopathy. The
analyses in this report were limited to 537 type 1 diabetic individuals with complete data who
participated in the last examination phase (2000–2001). Severe hypoglycemia was defined as
having one or more episodes of loss of consciousness or overnight hospitalization attributable to
hypoglycemia in a 1-year period before the examination.
RESULTS— The prevalence of severe hypoglycemia in this population was 14.3%. In uni-
variate analysis, current smokers had a greater chance of having severe hypoglycemia compared
with never smokers (odds ratio 2.40 [95% CI 1.30–4.40]). When we controlled for relevant
confounders such as age, sex, A1C, waist-to-hip ratio, orthostatic hypotension, alcohol con-
sumption, intensive insulin treatment, past history of severe hypoglycemia, and late complica-
tions of diabetes (nephropathy, neuropathy, and retinopathy), the association remained
statistically significant, with current smoking presenting2.6 times greater odds of developing
severe hypoglycemia.
CONCLUSIONS— Current smokers with type 1 diabetes have higher odds of severe hypo-
glycemia episodes.
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O ver the last few decades, new ther-apeutic agents have been intro-duced to improve glycemic
control and reduce complications of
type 1 diabetes. The Diabetes Control
and Complications Trial showed the
benefits of tight glycemic control, but it
also showed that individuals receiving
intensive insulin treatment had an in-
creased risk of developing severe hypo-
glycemia. Thus, this complication
remains a major challenge in treatment
of diabetic patients (1–5). Age, diabetes
duration, history of previous episodes
of hypoglycemia, intensive insulin
treatment, and lower levels of A1C have
been described previously as factors as-
sociated with this complication (1–5).
Smoking has been reported to be asso-
ciated with hypoglycemia in previous
clinical studies (6 – 8), and it has been
studied but not related to severe hypo-
glycemia in population-based studies.
Smoking, through its effect on hormone
regulation and insulin clearance, has
been hypothesized to result in severe
hypoglycemia (6 – 8). The purpose of
this study was to evaluate the relation-
ship of severe hypoglycemia and smok-
ing in a population-based study of
individuals with long-term type 1
diabetes.
RESEARCH DESIGN AND
METHODS— Thi s s tudy was a
cross-sectional analysis of the popula-
tion seen in the last examination
(2000 –2001) of the Wisconsin Epide-
miologic Study of Diabetic Retinopathy
(WESDR). The WESDR is an ongoing
prospective population-based cohort
study initiated in 1980 –1982 of indi-
viduals with type 1 and 2 diabetes living
in 11 counties of Wisconsin (9). Partic-
ipants were examined at baseline (n 
996) and every 4 – 6 years. The last ex-
amination phase (2000 –2001) was re-
stricted to individuals (n  652) with
type 1 diabetes. Detailed protocols used
in this period were published elsewhere
(10,11). Briefly, relevant evaluations in-
cluded history of hypoglycemic reac-
t ions, neuropathy, nephropathy,
cigarette smoking, and alcohol con-
sumption; measurements of blood pres-
sure in supine and standing positions,
A1C, height, weight, and hip and waist
circumference; and fundus photogra-
phy graded for diabetic retinopathy.
Definitions
Severe hypoglycemia was defined as
having one or more episodes of loss of
consciousness or overnight hospitaliza-
tion caused by hypoglycemia in a 1-year
period before the examination. There-
fore, two groups (with and without se-
vere hypoglycemia) were defined and
compared for the purpose of this study.
Participants were considered to be
never smokers if they had smoked
100 cigarettes in their lifetime, cur-
rent smokers if they had smoked 100
cigarettes and continue to smoke, and
past smokers if they had smoked 100
cigarettes but had stopped. All individ-
uals classified as past smokers had
stopped smoking for at least 12 months
in this study. Intensive insulin treat-
ment was defined as the use of three or
more insulin injections per day or use of
a continuous insulin pump. The defini-
tion of past history of severe hypoglyce-
mia only included positive history of
hospitalization due to hypoglycemia in
previous WESDR examinations because
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information about loss of consciousness
due to hypoglycemia was only obtained
in this last examination phase. Ortho-
static hypotension was defined as a de-
crease in systolic or diastolic blood
pressure of at least 20 or 10 mmHg, re-
spectively, after changing from supine
to standing positions. Neuropathy was
defined by positive history of tingling or
numbness in the hands, loss of tactile
sensation, or loss of temperature sensi-
tivity. Nephropathy was diagnosed if
the participant had been undergoing re-
nal dialysis, had renal transplantation,
or had gross proteinuria. Diabetic reti-
nopathy was assessed by fundus photo-
graphs and classified according to a
modified Early Treatment Diabetic Ret-
inopathy Study protocol (12). It was
categorized into three groups: none to
mild nonproliferative, moderate to se-
vere nonproliferative, and proliferative
retinopathy.
Data analysis
Statistical analysis consisted of univari-
ate analysis of continuous and categor-
ical data using Student’s t test and 2
test, respectively. Multivariate analysis
using logistic regression was performed
to adjust for several confounders: age,
sex, A1C, alcohol consumption, waist-
to-hip ratio, orthostatic hypotension,
intensive insulin treatment, and history
of severe hypoglycemia. Three different
regression models were built. Each
model contained the same confounders;
the only difference among them was the
presence of one of the variables related
to long-term complications of diabetes
(nephropathy, neuropathy, and reti-
nopathy). These variables were ana-
lyzed separately because of possible
correlations among them. Odds ratios
(ORs) with 95% CIs were estimated,
and P  0.05 was considered signifi-
cant. Analyses were performed in SAS
(SAS Institute, Cary, NC)
The institutional review board ap-
proved the study, and all participants pro-
vided consent. This research was
conducted in accordance with the princi-
ples of the Declaration of Helsinki.
RESULTS— A total of 537 individu-
als presenting complete data on insulin
reaction were included in the current
analysis. Compared with those who
were excluded because of incomplete
data (n  115), this group had lower
levels of A1C and lower waist-to-hip ra-
tios and tested their blood glucose more
frequently each day (data not shown).
The mean  SD age of this population
was 45.3  9.9 years, duration of dia-
betes was 31.3  7.9 years, and A1C
was 7.8  1.4%. Regarding insulin
treatment, 44.8% took insulin 3
times/day, 90.1% tested their glucose
levels using blood from a fingerstick
specimen (mean  SD 3.6  2.1 tests/
day), and 88.8% adjusted insulin as a
result of these glucose tests. The use of a
continuous insulin pump was observed
in 20.5% of this population. Most of the
part ic ipants were never smokers
(57.7%), 27.0% were past smokers, and
15.3% were current smokers. Smoking
status was similar in men and women;
pack-year history was 1.4 times higher
in men than women, although not sta-
tistically significant (P  0.11). Seven-
ty-eight individuals (14.5%) reported
one or more episodes of severe hypogly-
cemia in a period of 1 year. Table 1
shows the characteristics of the WESDR
cohort in the 2000 –2001 follow-up ac-
cording to severe hypoglycemia status.
In the univariate analysis, smoking
was significantly associated with the de-
velopment of severe hypoglycemia (Ta-
ble 2). Current smokers were more
likely to report a history of severe hypo-
glycemia compared with never smokers
(OR 2.40 [95% CI 1.30 – 4.40]). In mul-
tivariable analysis (Table 3), smoking
remained significantly associated with
severe hypoglycemia while controlling
for confounders in two models. ORs for
comparisons of current to never smok-
ers were 2.65 (1.20 –5.82), 2.68 (1.21–
5.92), and 2.10 (0.90 –5.01) for the
models including nephropathy, neu-
ropathy, and retinopathy, respectively.
No interactions were observed (with
age, sex, duration of diabetes, or inten-
sive insulin treatment).
CONCLUSIONS— The re la t ion-
ship of smoking and low blood glucose
was described in the 1950s when Bohan
and Berry (7) and Berry (6) published a
series of cases in which individuals with
type 1 diabetes had fewer hypoglycemic
episodes after smoking cessation. In our
study, current smokers were 2.6 times
as likely to report at least one episode of
severe hypoglycemia compared with
nonsmokers after controlling for rele-
vant confounders. One study in Den-
mark also showed that smoking was an
independent factor associated with se-
vere hypoglycemia, attributing this to
differences in lifestyle, carbohydrate
metabolism, and neuropathy (8). The
relation of smoking to severe hypogly-
cemia may be due to an effect of smok-
ing on insulin clearance, leading to
hyperinsulinemia, increasing the risk of
postprandial hypoglycemia, and wors-
ening metabolic control; such an effect
was found in individuals with type 2
diabetes (13). In addition, smoking has
been shown to increase the secretion of
hormones (i.e., growth hormone, argi-
nine vasopressin, and cortisol) that
counteract insulin action, leading to an
increased insulin requirement (14).
Smokers have been found to require
more insulin than nonsmokers to
achieve the same level of glycemic con-
trol in some, but not all, studies (15–
17). This increased insulin requirement
may also account for the higher suscep-
tibility to severe hypoglycemia in smokers.
Although the WESDR provided a
unique opportunity to analyze data
from a large population-based cohort of
type 1 diabetic individuals, there are
some limitations that should be consid-
ered. First, the definition of a history of
severe hypoglycemia included only
those who lost consciousness or were
hospitalized, whereas other studies
used a broader definition including all
individuals who had episodes of hypo-
glycemia that required help from an-
other indiv idua l (1 ,2 ,5 ,8) . This
difference might be reflected in the
prevalence found in our study (14.5%),
which approximates more the lower
end of prevalence values found by oth-
ers (4 – 40%) (2,5,8,18). Differences
might also be due to higher frequencies
of intensive insulin treatment in some
specialty clinics than in the general pop-
ulation of individuals with type 1 dia-
betes. Second, the history of severe
hypoglycemia was not validated by ex-
amination of medical records or mea-
surement of glycemia during the
episodes. Therefore, severe hypoglyce-
mia might have been misclassified in
some participants in our study. In addi-
tion, our assessment of smoking was
based on cigarette smoking only. There
were no questions regarding the use of
smokeless tobacco or other sources of
nicotine or exposure to passive smoking
in our questionnaire. Third, it is possi-
ble that excessive exogenous insulin use
may have resulted in residual con-
founding. However, we feel it was un-
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Table 1—Clinical characteristics of participants of the WESDR according to severe hypoglycemia status
All
Severe hypoglycemia
Yes No
n 537 78 459
Women (%) 49.9 51.3 49.6
Age (years) 45.3  9.9 44.1  10.7 45.5  9.7
BMI (kg/m2) 27.5  4.7 26.7  4.9 27.7  4.7
Waist-to-hip ratio 0.86  0.09 0.84  0.08* 0.86  0.09*
A1C (%) 7.8  1.4 7.8  1.6 7.8  1.4
Diabetes duration (years) 31.3  7.9 31.4  9.5 31.2  7.7
Intensive insulin treatment (%) 65.3 68.4 64.7
Number of times/day taking insulin 2.8  0.9 2.8  0.8 2.8  1.0
Test blood glucose by fingerstick (%) 90.1 97.4* 88.9*
Number of tests/day 3.6  2.1 4.0  2.2 3.6  2.1
Use of continuous pump (%) 20.5 23.7 19.9
Triglycerides (mg/dl) 99.5  68.8 100.04  68.7 99.45  68.9
Cholesterol (mg/dl) 179.2  35.2 185.6  35.5 178.1  35.0
LDL cholesterol (mg/dl) 102.8  30.9 106.2  33.4 102.2  30.4
HDL cholesterol(mg/dl) 56.8  15.9 59.4  15.9 56.3  15.9
Orthostatic hypotension (%) 16.5 15.8 16.7
Alcohol consumption (ounces/day) 0.17  0.4 0.17  0.5 0.17  0.3
Smoking (%)
Never 57.7 47.4 59.4
Past 27.0 26.9 27.1
Current 15.3 25.7† 13.5†
Past severe hypoglycemia (%) 4.6 7.9 4.1
Nephropathy (%) 25.1 28.2 24.6
Neuropathy (%) 47.2 52.6 46.3
Retinopathy (%)
None to mild NPDR 42.4 51.1 41.2
Moderate to severe NPDR 18.8 15.6 19.2
Proliferative 38.8 33.3 39.6
Data are means  SD or percent. *P  0.05; †P  0.01. NPDR, nonproliferative diabetic retinopathy.
Table 2—ORs and 95% CI in univariate analysis of factors related to severe hypoglycemia
OR (95% CI) P value
Sex, male vs. female 1.07 (0.67–1.72) 0.79
Age, 1 year increase 0.98 (0.96–1.01) 0.24
A1C, 1 SD increase 0.99 (0.79–1.25) 0.95
Waist-to-hip ratio, 1 SD increase 0.72 (0.54–0.96) 0.02
Orthostatic hypotension, present 0.94 (0.44–2.01) 0.86
Alcohol consumption, 1 SD increase 0.99 (0.78–1.27) 0.96
Smoking
Past vs. never smoker 1.25 (0.70–2.22) 0.45
Current vs. never smoker 2.40 (1.30–4.40) 0.01
Intensive insulin treatment, current 1.18 (0.70–1.99) 0.53
Past severe hypoglycemia, present 2.00 (0.76–5.21) 0.15
Neuropathy, present 1.28 (0.79–2.08) 0.30
Nephropathy, present 1.20 (0.70–2.05) 0.49
Diabetic retinopathy
Moderate to severe NPDR vs. none to mild
NPDR
0.65 (0.26–1.60) 0.59
Proliferative vs. none to mild NPDR 0.68 (0.33–1.36) 0.63
NPDR, nonproliferative diabetic retinopathy.
Hirai and Associates
DIABETES CARE, VOLUME 30, NUMBER 6, JUNE 2007 1439
likely to affect the association because
excessive insulin use has not been
shown to be related to smoking. Fourth,
although the WESDR is a prospective
study, we performed a cross-sectional
analysis because new information re-
garding insulin reactions and blood
pressure measurements in standing po-
sitions were only obtained in this last
phase (2000 –2001). As a consequence,
this type of analysis limits us from de-
termining antecedent-consequent rela-
tionships. Finally, the exclusion of
some participants in the analysis re-
sulted in a population with different
characteristics compared with the base-
line cohort that might have compro-
mised the generalizabil ity of our
findings. In a long-term perspective,
death was the most common cause for
exclusion. If smokers had a higher risk
of death, we might have underestimated
the strength of the association reported.
In addition, it is possible that individu-
als with complications such as neurop-
athy and nephropathy who had a
history of severe hypoglycemia were
more likely to die and not participate
than those without a history of severe
hypoglycemia, leading to the lack of a
finding with these complications. How-
ever, we believe the findings represent
results from those with long-term type 1
diabetes and are still generalizable to
such a group. Despite these limitations,
our study showed that current smokers
presented significantly higher odds for
severe hypoglycemia episodes com-
pared with never smokers in this cohort
of type 1 diabetic individuals.
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